ENROLLING_BY_INVITATION

CorEvitas Inflammatory Bowel Disease (IBD) Registry

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.

Official Title

CorEvitas Inflammatory Bowel Disease (IBD) Registry

Quick Facts

Study Start:2017-03-27

Study Completion:2100-12

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ENROLLING_BY_INVITATION

Study ID

NCT03162549

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* At least 18 years of age or older. * Willing and able to provide written consent for participation in the IBD Registry. * Willing and able to provide Personally Identifiable Information (PII) which includes the following types of personal information at a minimum: full name, date of birth, sex, and home address zip code. * Diagnosis of one of the following by a gastroenterologist: 1. Crohn's disease 2. Ulcerative colitis * Prevalent users or new /incident users of an approved biologic drug or JAK inhibitor (Tofacitinib) for the treatment of UC or Crohn's disease.	Pregnancy or breastfeeding Severe psychiatric disorders Active substance abuse Unstable medical conditions Inability to comply with study requirements

Inclusion Criteria

Exclusion Criteria

* At least 18 years of age or older.
* Willing and able to provide written consent for participation in the IBD Registry.
* Willing and able to provide Personally Identifiable Information (PII) which includes the following types of personal information at a minimum: full name, date of birth, sex, and home address zip code.
* Diagnosis of one of the following by a gastroenterologist:
1. Crohn's disease
2. Ulcerative colitis
* Prevalent users or new /incident users of an approved biologic drug or JAK inhibitor (Tofacitinib) for the treatment of UC or Crohn's disease.

Pregnancy or breastfeeding
Severe psychiatric disorders
Active substance abuse
Unstable medical conditions
Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Jeffrey Greenberg, MD

STUDY_DIRECTOR

CorEvitas, LLC

Study Locations (Sites)

CorEvitas, LLC

Waltham, Massachusetts, 02451

United States

Collaborators and Investigators

Sponsor: CorEvitas

Jeffrey Greenberg, MD, STUDY_DIRECTOR, CorEvitas, LLC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-03-27

Study Completion Date2100-12

Study Record Updates

Study Start Date2017-03-27

Study Completion Date2100-12

Terms related to this study

Additional Relevant MeSH Terms

Inflammatory Bowel Diseases